All News

Earlier treatment with Jakafi showed promise in both improving survival and symptom burden in certain patients with myelofibrosis, though physicians often delay Jakafi treatment.

Serious athletes may benefit from the training they did before diagnosis, but that doesn't mean it's too later for anyone to start movement during their cancer journey.

I've learned that with cancer, there’s a difference between cathartic venting (a natural stage of grief) and falling into a victim mindset.

An expert offers feasible tips on how patients with cancer can eat better — from incorporating quick and easy protein sources to effective supermarket shopping strategies.

My cancer support group was as important to my cure and healing as my oncologist and surgeon.

The phase 2 DESTINY-PanTumor02 trial included patients with HER2-expressing solid tumors such as bladder, pancreatic and rare tumors.

Bruton tyrosine kinase inhibitors have changed the space for treating patients with CLL or SLL, with more on the way to potentially address drug resistance.

Cancer-related decisions put strain on relationships between myself and family members.

“In the poker game of life, if you’re dealt a bad set of cards, the best you can do is play them as well as you can,” a cancer survivor said.

When mindfulness was first recommended when I was diagnosed with breast cancer in 2004, I scoffed. But now, years later, I know how important a tool it can be.

The Food and Drug Administration is reviewing remestemcel-L for the treatment of children with steroid-refractory acute graft-versus-host disease.

Positive results have emerged from a trial testing PIPAC, a procedure used for appendiceal, ovarian, gastric and colon cancers that works by spraying chemotherapy directly onto tumors.

A common — but toxic — flower is being used to treat cancer.

When I share my story and use my cancer diagnosis to help others, cancer becomes a “club” that’s a little more inviting.

A recent study finds patients who test positive for an HPV biomarker may not be positive for HPV itself, and these patients see significantly lower five-year survival rates.

My daughter continues to be there for me throughout my cancer experience, even on my most difficult days.

My oncology team works together to take great care of myself and other patients.

Patients with resectable non-small cell lung cancer treated with Imfinzi plus chemo before surgery or as monotherapy after surgery demonstrated significant improvements to event-free survival compared with those treated with neoadjuvant chemotherapy and surgery, study results show.

Cabometyx plus Tecentriq failed to improve progression-free survival in patients with kidney cancer.

My major source of support throughout my journey was our local breast cancer support group.

When I was in the throes of cancer, I didn't know how to answer well-meaning people who asked, "How you doin'?"

From a contestant on “Queer Eye” dying of cancer to a string of brain cancers in former Philadelphia Phillies players, here’s what’s happening in the oncology space this week.

Patients with HER2-positive metastatic breast cancer treated with the novel antibody drug conjugate ARX788 conferred a significant survival benefit compared with those treated with a control.

Keytruda plus chemotherapy before surgery and as single agent after improved outcomes for patients with resectable non-small cell lung cancer.

Regarding overall survival, allogeneic HCT did not have a benefit over consolidation chemotherapy in patients with intermediate-risk disease.

When my daughter was going through cancer treatment, we often heard the beeping of her chemotherapy IV. But recently, the memory of that sound was replaced with something much happier.

A cervical cancer survivor tells her story of how a MLM company urged her to use her diagnosis to sell more products.

Thanks to an amazing care team, I got through my breast cancer with little worry.

A new survey from HealthTree Foundation and Adaptive Biotechnologies shows that patients with multiple myeloma report significant clinical and emotional benefits from MRD testing and 90% of patients who have had MRD testing would recommend it to others, underscoring its benefits and providing support for broad clinical use.

The Food and Drug Administration accepted a supplemental Biologics License Application for Opdivo to treat stage 2B or C, fully resected melanoma.